Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 2
2019 6
2020 5
2021 1
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 management in Iran and international sanctions.
Pormasoumi H, Rostami D, Jamebozorgi K, Mirshekarpour H, Heshmatnia J. Pormasoumi H, et al. Among authors: rostami d. Eur J Transl Myol. 2022 Oct 5;32(4):10777. doi: 10.4081/ejtm.2022.10777. Eur J Transl Myol. 2022. PMID: 36200579 Free PMC article. Review.
The atherogenic role of immune cells in familial hypercholesterolemia.
Taghizadeh E, Taheri F, Gheibi Hayat SM, Montecucco F, Carbone F, Rostami D, Montazeri A, Sahebkar A. Taghizadeh E, et al. Among authors: rostami d. IUBMB Life. 2020 Apr;72(4):782-789. doi: 10.1002/iub.2179. Epub 2019 Oct 21. IUBMB Life. 2020. PMID: 31633867 Free article. Review.
Epigenetic aspects of multiple sclerosis and future therapeutic options.
Jamebozorgi K, Rostami D, Pormasoumi H, Taghizadeh E, Barreto GE, Sahebkar A. Jamebozorgi K, et al. Among authors: rostami d. Int J Neurosci. 2021 Jan;131(1):56-64. doi: 10.1080/00207454.2020.1732974. Epub 2020 Feb 25. Int J Neurosci. 2021. PMID: 32075477 Review.
Cellular and Molecular Aspects of Managing Familial Hypercholesterolemia: Recent and Emerging Therapeutic Approaches.
Taheri F, Taghizadeh E, Baniamerian F, Rostami D, Rozeian A, Mohammad Gheibi Hayat S, Jamialahmadi T, Reiner Ž, Sahebkar A. Taheri F, et al. Among authors: rostami d. Endocr Metab Immune Disord Drug Targets. 2022;22(10):1018-1028. doi: 10.2174/1871530322666220509040844. Endocr Metab Immune Disord Drug Targets. 2022. PMID: 35532248 Review.
15 results